Clinical Trial Update: HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/Phase 2 clinical trial evaluating trametinib with dexamethasone and chemotherapy in children with relapsed or refractory acute lymphoblastic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• DEXAMETHASONE (Dexamethasone)
• Trametinib (trametinib)

Snippet

Sponsor: Princess Maxima Center for Pediatric Oncology | Conditions: Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Phase 1, Phase 2 | Status: RECRUITING